Cell death or survival promoted by alternative isoforms of ErbB4

Maria Sundvall1, Ville Veikkolainen, Kari Kurppa

  • 1Department of Medical Biochemistry and Genetics, and Medicity Research Laboratory, University of Turku, Turku, Finland; Department of Oncology, Turku University Hospital, FIN-20520 Turku, Finland.

Insights

Two ErbB4 isoforms have opposite effects on cell growth and survival. ErbB4 JM-a promotes growth, while ErbB4 JM-b induces death, impacting tumor biology and ErbB4 inhibitor therapies.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Cancer Research

Background:

  • The role of ErbB4 in tumor biology remains unclear.
  • The ERBB4 gene produces multiple isoforms through alternative splicing, including juxtamembrane (JM-a, JM-b) and cytoplasmic (CYT-1, CYT-2) variants.

Purpose of the Study:

  • To compare signaling pathways mediated by two specific ErbB4 isoforms: JM-a CYT-2 and JM-b CYT-2.
  • To investigate the differential regulation of target genes by these ErbB4 isoforms.

Main Methods:

  • Comparative analysis of signaling via ErbB4 JM-a CYT-2 and JM-b CYT-2 isoforms in fibroblasts.
  • Identification of ErbB4 target genes using molecular and cellular assays.
  • Assessment of the role of Platelet-derived growth factor receptor-alpha (PDGFRA) and transcription factor AP-2 in ErbB4 isoform-mediated signaling.

Main Results:

  • ErbB4 JM-a isoform expression enhanced ErbB4 autophosphorylation, cell growth, and survival.
  • ErbB4 JM-b isoform overexpression led to starvation-induced cell death.
  • Platelet-derived growth factor receptor-alpha (PDGFRA) was identified as a differentially regulated target gene, with its transcription influenced by the soluble intracellular domain of ErbB4 interacting with AP-2.
  • JM-a isoform-mediated survival was dependent on PDGFR-α and AP-2, while JM-b isoform-induced cell death could be rescued by PDGF-BB.

Conclusions:

  • The two alternative ErbB4 JM isoforms (JM-a and JM-b) can mediate opposing cellular responses, affecting cell survival and growth.
  • These findings highlight the complexity of ErbB4 signaling in cancer.
  • Pharmacological targeting of ErbB4 kinase activity may result in either promoting or inhibiting cellular growth, depending on the specific isoform involved.

Related Concept Videos

Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...